Omri Amirav-Drory, PhD
Board Member
Board of Directors
Bio
Omri Amirav-Drory is the General Partner at NFX Bio and a seasoned scientist-operator turned investor. He was the Founding CEO of Genome Compiler, which was acquired by Twist Bioscience, where he later served as Head of Corporate Development. Omri went on to found Tech.Bio, investing in and advising leading techbio companies like Mammoth Biosciences and Immunai. Now at NFX, he champions Scientist-CEOs and envisions a future where they are the standard.